Guided Poster Tour

GUIDED POSTER TOUR 1 - Liffey Hall 1 Monday, June 18, 2012 12:45 - 14:15

Basic Science


The AAA-ATPase VPS4 regulates extracellular secretion and lysosomal targeting of α-synuclein

T. Hasegawa, M. Konno, T. Baba, N. Sugeno, A. Kikuchi, E. Miura, A. Takeda (Sendai, Japan)


GDNF replacement augments motor impairments and nigrostriatal dopamine deficits in 12 month old mice with a partial deletion of GDNF

H.A. Boger, G.A. Gerhardt, A. C. Granholm, O.M. Littrell (Charleston, SC, USA)


Characterization of adult neurogenesis in a transgenic mouse model of multiple system atrophy

P. Fuchs, L. Aigner, W. Poewe, G.K. Wenning, N. Stefanova (Innsbruck, Austria)


ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome

A. Grünewald, B. Arns, P. Seibler, A. Rakovic, A. Münchau, A. Ramirez, C.M. Sue, C. Klein (Lübeck, Germany)


A rodent model for direct visualization of α-synuclein oligomers in the nigrostriatal system

L.V. Kalia, H. Dimant, S.K. Kalia, L.N. Kibuuka, D. Ebrahimi-Fakhari, N.R. McFarland, P.J. McLean (Toronto, ON, Canada)


Inflammatory responses are attenuated in incidental Lewy body disease

R.S. Akhtar, J.M. Milber, J.V. Noorigian, L.R. White, H. Petrovitch, G.W. Ross, J.E. Duda (Philadelphia, PA, USA)


Mild dopaminergic lesions are accompanied by robust changes in subthalamic nucleus activity

M.L.F. Janssen, D.G.M. Zwartjes, S.K.H. Tan, R. Vlamings, A. Jahanshahi, T. Heida, G. Hoogland, H.W.M. Steinbusch, V. Visser-Vandewalle, Y. Temel (Maastricht, Netherlands)


Enteric and central nervous system pathology in a novel mouse model: Implications for pathogenesis in pre-motor Parkinson's disease

L.P. Kelly, P.M. Carvey, R.A.E. Bakay, J.H. Kordower (Chicago, IL, USA)


Implication of autophagy in Parkinson's disease: Rotenone-based models

N. Xiong, M. Jia, J. Xiong, J. Huang, T. Wang (Wuhan, China)

GUIDED POSTER TOUR 2 - Liffey Hall 2 Monday, June 18, 2012 12:45 - 14:15

Lewy Body Dementia and other dementias in movement disorders


Withdrawn by Author



Cerebral vasculitis mimicking frontotemporal dementia

A. Mc Carthy, E. Mulroy, K. O'Rourke, T. Lynch (Dublin, Ireland)


Comparison of The Movement Disorder Society criteria for Parkinson's disease dementia with routine clinical neuropsychological testing

B.R. Barton, B. Bernard, G.T. Stebbins, J. Goldman, B. Dubois, C.G. Goetz (Chicago, IL, USA)


Parkinson's disease patients fulfilling level-I criteria for dementia differ in ADL functions and phenotype

I. Liepelt-Scarfone, D. Prakash, J.B.M. Christ, E. Riedl, I. Csoti, M. Fruhmann Berger, S. Graeber, D. Berg (Tuebingen, Germany)


The evolutionarily conserved function of HtrA2 in mice prevents neurodegeneration by oligomeric α-synuclein

M.M. Rahman, M. L. Liu, S. Akhter, H.J. Kim, S.T. Hong (Jeonju, Korea)


Safety, tolerability, and efficacy of armodafinil therapy for hypersomnia associated with dementia with Lewy bodies

B. Boeve, K. Kuntz, D. Drubach, L. Allen, D. Drubach (Rochester, MN, USA)


Neuropsychological differences in mild cognitive impairment (MCI) with symptoms of Lewy body disease (LBD)/Parkinson's disease (PD) and other MCI causes

M.J. García Basalo, D.J. Bauso, J.P. Tartari, C.V. Stefani, N. Cámpora, M. Fernández, J.I. Rojas, E. Cristiano, A. Golimstok (Buenos Aires, Argentina)


Pathological accumulation of α-synuclein and Aβ in Parkinson's disease with dementia

M.C. Campbell, P.T. Kotzbauer, N.J. Cairns, B.A. Racette, S.D. Tabbal, J.S. Perlmutter (St. Louis, MO, USA)


Elevated homocysteine levels predict cognitive dysfunction in an incident cohort of non-demented Parkinson's disease patients

G.W. Duncan, T.K. Khoo, A.J. Yarnall, J.T. O'Brien, D.J. Brooks, R.A. Barker, D.J. Burn (Newcastle upon Tyne, United Kingdom)


Cognitive symptoms in a population-based cohort to study parkinsonism

E. J. Vollstedt, J. Graf, A. Lorwin, J. Hagenah, V. Tadic, N. Brüggemann, A. Schmidt, S. Tunc, J. Hampf, L. Piskol, C. Klein, M. Kasten (Lübeck, Germany)

GUIDED POSTER TOUR 3 - Wicklow Hall 1 Monday, June 18, 2012 12:45 - 14:15

Parkinson's disease: Cognition


Correlation of cognitive impairment evaluated by Montreal Cognitive Assessment with functional brain imaging of Parkinson's disease patients

K. Ohta, T. Osada, T. Tajima, M. Seki, Y. Shinohara (Tokyo, Japan)


Visual sampling during walking in people with Parkinson's disease and the influence of task complexity

S. Lord, B. Galna, D. Daud, N. Archibald, D. Burn, L. Rochester (Newcastle upon Tyne, United Kingdom)


Severe olfactory dysfunction is predictive of dementia associated with Parkinson's disease: A 3-year longitudinal study

T. Baba, A. Kikuchi, K. Hirayama, Y. Nishio, Y. Hosokai, S. Kanno, T. Hasegawa, N. Sugeno, M. Konno, E. Miura, E. Mori, A. Takeda (Sendai, Japan)


A novel test for assessing gait under multiple-task conditions: Comparison of the performance among adults, elderly and patients with Parkinson's disease

E. Tardeli, N. Santo, R. Bovi, D. Bertolo, M.E.P. Piemonte (Sao Paulo, Brazil)


Olfactory dysfunction correlation to non-motor symptoms in Parkinson's disease patients

G.J. Lopez, K. Bayulkem, B. McElroy, M. Brooks, B. Bayulkem, M. Hallett (Bethesda, MD, USA)


GBA mutation carriers with Parkinson's disease are not at increased risk for cognitive impairment

I. Mata, J. Leverenz, J. Trojanowski, A. Chen-Plotkin, B. Ritz, S. Rhodes, S. Factor, C. Wood-Siverio, J. Quinn, K. Chung, A. Espay, F. Revilla, K. Edwards, T. Montine, C. Zabetian (Seattle, WA, USA)


Association between olfactory dysfunction and cognition in the PPMI study

A. Siderowf, J.F. Morley, J.E. Duda, D. Weintraub, For the PPMI Investigators (Philadelphia, PA, USA)


Motor impulsivity in Parkinson's disease subtypes: Postural instability with gait difficulty versus tremor predominant

D.O. Claassen, S.A. Wylie (Nashville, TN, USA)


Dual task effects during sentence production in Parkinson's disease

J.P. Wilson, L.J.P. Altmann, A.A. Hazamy, E. Stegemöller, M.S. Okun, C.J. Hass (Gainesville, FL, USA)


Baseline data of the DeNoPa-Kassel cohort: Biomarkers and non-motor features of 160 drug naïve PD subjects and 115 matched healthy controls

B. Mollenhauer, E. Trautmann, T. Wicke, J. Ebentheuer, F. Sixel-Döring, C. Trenkwalder, DeNoPa Study Group (Kassel, Germany)

GUIDED POSTER TOUR 4 - Wicklow Hall 2 Monday, June 18, 2012 12:45 - 14:15

Sleep disorders and RLS


Restless legs syndrome in Korean patients with drug-naïve Parkinson's disease: A nation-wide study

J. Youn, H.Y. Shin, W.T. Yoon, J.S. Kim, H. Shin, J.Y. Ahn, J.W. Cho (Seoul, Korea)


Quantifying daytime sleepiness in Parkinson's disease

K. Kotschet, W. Johnson, R. Griffiths, M. Horne (Fitzroy, Australia)


How does parkinsonism start? Prodromal parkinsonism motor changes in idiopathic REM sleep behavior disorder

R.B. Postuma, A.E. Lang, J.F. Gagnon, A. Pelletier, J. Montplaisir (Montreal, QC, Canada)


Restless legs syndrome outside the blood-brain barrier – Evidence from domperidone

S. Rios Romenets, Y. Dauvilliers, V. Cochen De Cock, B. Carlander, S. Bayard, C. Galatas, C. Wolfson, R. Postuma (Montreal, QC, Canada)


Sleep and circadian rhythm disruption in incident Parkinson's disease – A multimodal analysis

D.P. Breen, R. Vuono, K. Fisher, S. Nawarathna, J.M. Shneerson, A.B. Reddy, R.A. Barker (Cambridge, United Kingdom)


REM sleep without atonia and freezing of gait in Parkinson's disease

A. Videnovic, C.C. Marlin, J. Planetta, L. Alibiglou, D.E. Villancourt, C.D. MacKinnon (Chicago, IL, USA)


Effects of dopaminergic medications on objective and subjective sleep in Parkinson's disease

L.M. Chahine, J. Daley, S. Horn, A. Colcher, H. Hurtig, C. Cantor, N. Dahodwala (Philadelphia, PA, USA)


A rare variant near a potassium channel-related gene in familial restless legs syndrome

I. Pichler, C. Schwienbacher, A. Zanon, C. Fuchsberger, A. Serafin, F. Marroni, M.F. Facheris, C. Tellgren-Roth, U. Gyllensten, J.F. Gusella, A.A. Hicks, P.P. Pramstaller (Bolzano, Italy)


Comparison of pregabalin, pramipexole and placebo effects on symptoms, limb movements and sleep maintenance in restless legs syndrome (Willis-Ekbom disease)

R.P. Allen, P.M. Becker, J. Patrick, S. Dubrava, D. Garcia-Borreguero, A. Lankford, C. Chen, L. Knapp, J. Miceli (Baltimore, MD, USA)


Sleep disturbances and dysautonomic dysfunction are associated in patients with Parkinson's disease

S. Realmuto, V. Arnao, A. Cinturino, F. Valentino, G. Famoso, V. Perini, S. Mastrilli, P. Aridon, P. Ragonese, G. Savettieri, M. D'Amelio (Palermo, Italy)

GUIDED POSTER TOUR 5 - Liffey Hall 1 Tuesday, June 19, 2012 12:15 - 13:45

Parkinson's disease: Clinical trials


Bilateral STN stimulation reduces the occurrence of freezing of gait in Parkinson's disease

H. Devos, G. Vervoort, L. Münks, W. Vandenberghe, B. Nuttin, A. Nieuwboer (Leuven, Belgium)


Fox Trial Finder (FTF): Online clinical trial matching to connect subjects with Parkinson's trials

M. Frasier, S. Chowdhury, C.C. Meunier, D. Brooks (New York, NY, USA)


Continuous subcutaneous carbidopa improves levodopa pharmacokinetics in Parkinson's disease patients

Y. Caraco, N. Giladi, S. Oren, P.A. LeWitt (Jerusalem, Israel)


A phase III clinical trial of coenzyme Q10 (QE3) in early Parkinson's disease: Parkinson Study Group QE3 Investigators

M.F. Beal (New York, NY, USA)


Accordion pill carbidopa/levodopa for improved treatment of advanced Parkinson's disease symptoms

P.A. LeWitt, H. Friedman, N. Giladi, T. Gurevich, H. Shabtai, R. Djaldetti, N. Roizen, S. Hassin-Baer, O. Cohen, G. Yahalom, I. Schlesinger, M. Nassar, R. Milo, N. Navon (Jerusalem, Israel)


Strength training outcomes for airway protection in PD

C.M. Sapienza, M. Troche, E.P. Silverman, J. Rosenbek, N. Musson (Gainesville, FL, USA)


Gait improvement in patients with Parkinson's disease after training in real and virtual enviroment

J.E. Pompeu, F.A. Mendes, K.G. Silva, T.P. Oliveira, A.M. Lobo, S.M.A.A. Pompeu, A.P. Zomignani, M.E.P. Piemonte (São Paulo, Brazil)


Dopamine agonists and dyskinesia in advanced Parkinson's disease: A network meta-analysis of rotigotine, pramipexole and ropinirole as adjunct therapy to levodopa

E. Senior, P. Dedeken, H. Naci (Brussels, Belgium)


Randomized, double-blind, double-dummy study of continuous infusion of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: Efficacy and safety

C.W. Olanow, A. Antonini, K. Kieburtz, H.H. Fernandez, A.J. Espay, D.G. Standaert, A.D. Vanagunas, K.L. Widnell, S. Freeman, W.Z. Robieson, Y. Pritchett, K. Chatamra, J. Benesh, R.A. Lenz (New York, NY, USA)


Randomized, phase 3, double-blind, double-dummy study of levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease: Functional and quality-of-life outcomes

K. Kieburtz, A. Antonini, C.W. Olanow, H.H. Fernandez, A.J. Espay, D.G. Standaert, S. Hass, K.L. Widnell, W.Z. Robieson, Y. Pritchett, K. Chatamra, J. Benesh (Rochester, NY, USA)

GUIDED POSTER TOUR 6 - Liffey Hall 2 Tuesday, June 19, 2012 12:15 - 13:45

Surgical Therapy: Parkinson's disease


Effects of subthalamic nucleus lesions and stimulation upon corticostriatalafferents in the 6-hydroxydopamine-lesioned rat

R.H. Walker, C. Moore, G. Davies, L. Dirling, R.J. Kock, C.K. Meshul (Bronx, NY, USA)


Evaluation of electrode design on activation volumes produced during deep brain stimulation

S.N. Washburn, C.R. Butson (Plano, TX, USA)


Parkinson's Study Group Neurosurgical Working Group (PSG-NSWG) deep brain stimulation (DBS) non-motor symptoms (NMS) survey: Real-world preoperative practice patterns

M.K. York, L. Marsh, J. Jimenez-Shahed, M.S. Okun, E. Moro, R. Kumar (Houston, TX, USA)


Deep brain stimulation and decision making in apathetic patients: A PET study

F. Antonelli, A.P. Strafella, Y.Y. Poon, A.M. Lozano, M. Hodaje, G. Pellecchia, F. Valzania, J.H. Ko, A. Lang, S. Houle, E. Moro (Toronto, ON, Canada)


Comprehensive, multi-disciplinary DBS screening for Parkinson's patients: No room for “short cuts”

H. Abboud, A. Machado, M. Deogaonkar, A. Ahmed, M. Gostkowski, S. Cooper, I. Itin, P. Sweeney, M. Pandya, C. Kubu, D. Floden, P. Ford, H. Fernandez (Cleveland, OH, USA)


Is age a predictor for length of hospital stay in deep brain stimulation?

E.M. Presant, Y. Song, P. Konrad, J. Neimat, F. Phibbs (Nashville, TN, USA)


Saccadic eye movement abnormalities in Parkinson's disease treated by levodopa and deep brain stimulation

M. Dec, M. Rudzinska, M. Tutaj, A. Szczudlik (Kraków, Poland)


The dominant subthalamic nucleus: A gait analysis study

M.G. Rizzone, I. Carpinella, C.A. Artusi, M. Lanotte, L. Lopiano, A. Marchisio, A. Merola, M. Rabuffetti, D.V. Roccatagliata, M. Zibetti, M. Ferrarin (Torino, Italy)


Randomized multicenter trial comparing bilateral subthalamic nucleus DBS and bilateral globus pallidus internus DBS for advanced Parkinson's disease (NSTAPS)

V.J. Odekerken, T. van Laar, A. Mosch, J. van Vugt, P.C. Nijssen, B.A. Schmand, P.R. Schuurman, R.M. de Bie (Amsterdam, Netherlands)


Stereotactic neurosurgery for movement disorders in a world perspective. Results from the WSSFN-supported survey

V. Jourdain, G. Schechtmann (Stockholm, Sweden)

GUIDED POSTER TOUR 7 - Wicklow Hall 1 Tuesday, June 19, 2012 12:15 - 13:45

Rating scales and assessment tools


Patient-centeredness in Parkinson's disease care: Development and validation of a patient experience questionnaire

M. van der Eijk, M.J. Faber, J.W.M. Aarts, M. Munneke, B.R. Bloem (Nijmegen, Netherlands)


How slow is too slow? Objective measurement of bradykinesia in Parkinson's disease using novel non-invasive devices

J.E. Alty, S. Jamieson, M.A. Lones, S.L. Smith (Leeds, United Kingdom)


Calibration of the UPDRS to the MDS-UPDRS

G.T. Stebbins, C.G. Goetz, B.C. Tilley (Chicago, IL, USA)


How should pushing off or the use of assistive devices be incorporated in the timed Up and Go (TUG)?

P.N. Schmidt, J.G. Nutt, M. Guttman, A.D. Siderowf, E.C. Nelson, J. Zamudio, M.S. Okun (Miami, FL, USA)


The association between NT-proCNP, functional capacity and clinical stage in patients with Parkinson's disease

D. Koziorowski, R. Tomasiuk, S. Szlufik, A. Friedman (Warsaw, Poland)


Determining minimal clinically important difference for health-related quality of life scales in Parkinson's disease

Y. Winter, D. Lubbe, W.H. Oertel, R. Dodel (Marburg, Germany)


Freezing of gait in Parkinson's disease: Associations with disease severity, falls, quality of life and clinical balance measures

R.A. Gruber, L.R.S. Almeida, J.H. Goldstein Elman, N.N. Negreiros, G.T. Valenca (Toronto, ON, Canada)


Metric evaluation of a novel scale to assess psychosis in patients with Parkinson's disease

W.G. Ondo, H. Peng (Houston, TX, USA)


Quantifying freezing of gait in Parkinson's disease during the instrumented timed Up and Go test

F.B. Horak, M. Mancini, R. Cohen, J.J. Nutt (Portland, OR, USA)


MDS-UPDRS non-English translation program

C.G. Goetz, G.T. Stebbins, N. LaPelle, J. Huang, B.C. Tilley (Chicago, IL, USA)

GUIDED POSTER TOUR 8 - Wicklow Hall 2 Tuesday, June 19, 2012 12:15 - 13:45

Parkinson's disease: Neuropharmacology


Determination of plasma, brain and cerebrospinal fluid levels of L-DOPA in the MPTP-lesioned cynomolgus macaque model of Parkinson's disease

P. Huot, T.H. Johnston, J.B. Koprich, S.H. Fox, J.M. Brotchie (Toronto, ON, Canada)


Medication reminder service for mobile phones; an open usability study in patients with Parkinson's disease

T. Keränen, S. Liikkanen (Kuopio, Finland)


Maintenance of constant steady state therapeutic plasma concentrations of levodopa following its continuous subcutaneous administration with carbidopa

O. Yacoby-Zeevi, P.A. LeWitt (West Bloomfield, MI, USA)


Adherence to once-daily dopamine agonists in levodopa-treated Parkinson's disease patients is related to first dopamine replacement therapy

D. Santos-García, M. Prieto-Formoso, R. de la Fuente- Fernández (Ferrol, Spain)


European multicentre survey of tolerability rates and impulse control behaviour trends of prolonged release dopamine agonists in young and old PD

A. Rizos, P. Martinez-Martin, A. Martin, T. Henriksen, B. Kessel, I. Koch, G. Durner, A. Antonini, P. Odin, C. Falup-Pecurariu, P. Reddy, S. Robinson, M. Silverdale, G. MacPhee, A. Douiri, S. Lindvall, K. Ray Chaudhuri (London, United Kingdom)


Human microdyalisis during acute high frequency stimulation of internus globus pallidus increases dopamine release and improves parkinsonian symptoms

R.R.C. Martinez, M.C. Carvalho, M.L. Brandão, M.J. Teixeira, J. Navarro, E.T. Fonoff (São Paulo, Brazil)


A multicentre European comparative survey of motor and non motor effects of subcutaneous apomorphine infusion and intrajejunal levodopa infusion in Parkinson's disease

P. Reddy, P. Martinez-Martin, A. Antonini, D. Calandrella, M. Pilleri, P. Odin, A. Martin, T. Henriksen, A. Rizos, R. Katzenschlager, N. Bryndum, A. Glad, L. Timmermann, H. Salimi Dafsari, G. Ebersbach, M.G. Kramberger, M. Trost, Z. Pirtosek, K. Wenzel, V. Tomantschger, A. Storch, H. Reichmann, A. Ceballos-Baumann, K.R. Chaudhuri (London, United Kingdom)


Parkinson's disease responding to smoking

A. Mc Carthy, K. O'Rourke, T. Lynch (Dublin, Ireland)


Peripheral neuropathy during continuous levodopa duodenal infusion: Outcome of 15 patients

F. Mancini, C. Comi, D. Calandrella, M. Lacerenza, G. Riboldazzi, C. Pacchetti, M. Coletti Moia, L. Manfredi, A. Antonini (Milan, Italy)


L-745,870 reduces L-DOPA-induced dyskinesia in the MPTP-lesioned primate at doses at which it is a selective antagonist at D4 dopamine receptors

P. Huot, T.H. Johnston, J.B. Koprich, S.H. Fox, J.M. Brotchie (Toronto, ON, Canada)

GUIDED POSTER TOUR 9 - Liffey Hall 1 Wednesday, June 20, 2012 12:00 - 13:30



CAG analysis, haplotypes, unstable repeats, recombination, pedigrees, gene dosage, genotype-phenotype relationship and genetics polymorphisms in the SCA2 (ATXN2) locus

J.M. Laffita-Mesa, L.C. Velázquez-Pérez, Y. Vázquez Mojena, V. Kourí, A. Martínez, A. Miranda, L. Peña Serrano, D.A. Cuello Almarales, R. Aguilera Rodriguez, V. Berovides (Holguin, Cuba)


PRRT2 mutations are a major cause of paroxysmal kinesigenic dyskinesia in the European population

A. Méneret, D. Grabli, C. Depienne, C. Gaudebout, F. Picard, A. Dürr, I. Lagroua, D. Bouteiller, M. Vidailhet, A. Brice, E. Roze (Paris, France)


High COMT activity is associated with earlier age at onset in PD

S. Klebe, J.L. Golmard, R. Charfi, G. Kuhlenbäumer, C. Klein, J. Hagenah, T. Gasser, I. Wurster, S. Lesage, D. Lorenz, G. Deuschl, M. Saad, M. Martinez, F. Durif, P. Pollak, P. Damier, F. Tison, A. Dürr, P. Amouyel, J.C. Lambert, C. Tzourio, C. Maubaret, F. Charbonnier-Beaupel, K. Tahiri, M. Vidailhet, A. Brice, J.C. Corvol (Paris, France)


Is the brain-derived neurotrophic factor (BDNF) Val66Met genetic polymorphism associated with impulsive-compulsive behaviours in Parkinson's disease?

S.S. O'Sullivan, P. Cheshire, A. Djamshidian, K. Bertram, D.R. Williams, A.J. Lees, T. Foltynie (Cork, Ireland)


First genome-wide association study in multiple system atrophy

A. Sailer, on behalf of the MSA GWAS Consortium (London, United Kingdom)


PINK1-dependent mitophagy in dopaminergic neurons does not require LC3 conversion

A. Rakovic, K. Shurkewitsch, P. Seibler, D. Krainc, C. Klein (Lübeck, Germany)


A clinicopathological study of parkin-linked parkinsonism – A study of 5 cases and comparison with Parkinson's disease

K.M Doherty, L. Silveira-Moriyama, L. Parkkinen, D. Healy, M. Farrell, N.E. Mencacci, Z. Ahmed, F. Brett, J. Hardy, N. Quinn, T.T. Counihan, T. Lynch, T. Revesz, A.J. Lees, J.L. Holton (London, United Kingdom)


Contiguous gene deletions involving the SGCE gene: A clinical description

K.J. Peall, A.J. Waite, M.A. Kurian, M. Smith, H. Pall, T. Nestor, M.D. King, D.J. Blake, M.J. Owen, H.R. Morris (Cardiff, United Kingdom)


Prrt2 gene mutations: From paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine

A. Gardiner, K.P. Bhatia, M. Stameou, R.C. Dale, M. Kurian, S. Schneider, G.M. Wali, T. Counihan, S. Spacey, E.M. Valente, L. Silveira-Moriyama, H.A. Taive, S. Raskin, J.W. Sander, A. Lees, T. Warner, D. Kullman, N.W. Wood, M. Hanna, H. Houlden (London, United Kingdom)


Alpha-synuclein H50Q, a novel pathogenic mutation for Parkinson's disease

S. Appel-Cresswell, C. Vilarino-Guell, I. Yu, B. Shah, D. Weir, C. Thompson, J.A. Stoessl, M.J. Farrer (Vancouver, BC, Canada)

GUIDED POSTER TOUR 10 - Liffey Hall 2 Wednesday, June 20, 2012 12:00 - 13:30

Parkinson's disease: Phenomenology


Abnormalities of voice quality in the course of disease progression in Parkinson's disease

W. Grönheit, U. Schlegel, S. Skodda (Bochum, Germany)


An observational study of the impact of early versus delayed treatment on quality of life in Parkinson's disease

D.J.M. McGhee, R. Caslake, C.E. Harris, C.E. Counsell (Aberdeen, United Kingdom)


Asymmetry of gait in parkinsonian patients and its role in the development of freezing

G. Frazzitta, G. Pezzoli, G. Bertotti, G. Riboldazzi, R. Rovescala, R. Maestri (Montescano, Italy)


Baseline findings and Parkinson's disease prognosis

A.H. Rajput, M.L. Rajput, A.H. Rajput (Saskatoon, SK, Canada)


Progressive cortical degeneration in Parkinson's disease

D. Benninger, J. Dukart, J. von Meyenburg, S. Thees, C. Bassetti, D. Waldvogel, S. Kollias, K. Iseki, B. Draganski (Lausanne, Switzerland)


Unexplained lower limb pain syndrome in Parkinson's disease: A variant of central pain

A. Martin, S. Robinson, M. Parry, A.H.V. Schapira, A. Rizos, C. Clough, K. Ray Chaudhuri (London, United Kingdom)


The CamPaIGN study of incident Parkinson's disease: Natural history over the first 10 years

C.H. Williams-Gray, S.L. Mason, J.R. Evans, T. Foltynie, R.A. Barker (Cambridge, United Kingdom)


Cognitive correlates of freezing phenomenon in Parkinson's disease

E. Stefanova, M. Jecmenica Lukic, F. Agosta, V. Spica, M. Filippi, V. Kostic (Belgrade, Serbia)


Patterns of daily ambulatory activity are different in early Parkinson's disease compared with controls

S. Lord, A. Godfrey, B. Galna, D. Burn, L. Rochester (Newcastle upon Tyne, United Kingdom)


Freezing of gait in Parkinson's disease under virtual reality conditions studied with a novel treadmill system: A pilot trial

K. Czarnecki, K. Iseki, C.R. Collins, P.T. Ghosh, H.S. Park, J.W. Yoon, M. Hallett (Bethesda, MD, USA)

GUIDED POSTER TOUR 11 - Wicklow Hall 1 Wednesday, June 20, 2012 12:00 - 13:30

Huntington's disease


Frontal subcortical dysfunction underlying the applause sign: A study in Huntington's disease subjects

S. Nageshwaran, Y. Bordelon, S. Perlman (London, United Kingdom)


Molecular analysis of Huntington's disease in a Cuban population

Y. Vázquez-Mojena, J.M. Laffita-Mesa, L. Laguna-Salvia, Y. González-Zaldívar, D. Almaguer-Gotay, P. Zayas-Feria, L.E. Almaguer-Mederos, R. Rodríguez-Labrada, L. Velázquez-Pérez (Holguin, Cuba)


A proposal for a physiotherapy programme to improve gait, balance and functional independence in Huntington's disease

T. Capato, M. Haddad, M.E. Piemonte, E.R. Barbosa (Sao Paulo, Brazil)


Antisense oligonucleotides as molecular tools to silence prolonged (CAG)n tracts in Huntington's disease

R. Vlamings, M.M. Evers, W.M.C. van Roon-Mom, S.A.M. Mulders, M.L.F. Janssen, R.C. Verheul, J.C.T. van Deutekom, Y. Temel (Maastricht, Netherlands)


Bilateral globus pallidus deep brain stimulation for Huntington's disease: Long term outcome of chorea

V. Gonzalez, L. Cif, B. Biolsi, M. Zanca, E. Sanrey, A.M. Moura, T. Roujeau, S. James, P. Coubes (Montpellier, France)


Baseline characteristics of the PREQUEL cohort: An interventional trial in pre-manifest Huntington's disease

A. Killoran, K.M. Biglan, E. Julian-Baros, N. Yoritomo, C.A. Ross (Rochester, NY, USA)


Concomitant use of antidepressants and neuroleptics with tetrabenazine during treatment of Huntington's disease

V. Shen, K. Clarence-Smith, C. Hunter, J. Jankovic (Deerfield, IL, USA)


Long-term safety and efficacy of tetrabenazine in the treatment of chorea associated with Huntington's disease

V. Shen, K. Clarence-Smith, C. Hunter, J. Jankovic (Deerfield, IL, USA)


Cognitive decline in Huntington's disease is associated with CAG repeat length

A. Hellman, B. Durbin-Johnson, X.R. Chen, D. Harvey, C. Decarli, T. Tempkin, V. Wheelock (Philadelphia, PA, USA)


Neuropathology of McLeod neuroacanthocytosis syndrome

H.H. Jung, F. Geser, J. Haybäck, B. Bader, A. Danek, P. Fuhr, M. Neumann, R. Reichard, B. Udd, A. Zeman, M. Tolnay (Zürich, Switzerland)

GUIDED POSTER TOUR 12 - Wicklow Hall 2 Wednesday, June 20, 2012 12:00 - 13:30

Parkinson's disease: Behavorial disorders


The neural correlates of visual misperceptions in Parkinson's disease: Disorder of attentional networks

J.M. Shine, G.M. Halliday, S.J. Bolitho, S.L. Naismith, S.J.G. Lewis (Sydney, Australia)


Creative thinking in patients with Parkinson's disease and healthy subjects: The artistic profession makes the difference?

M. Canesi, M.L. Rusconi, E. Reali, F. Moroni, R. Cilia, G. Pezzoli (Milan, Italy)


Decision-making, impulsivity and behavioural addictions: Do Parkinson's patients jump to conclusions?

A. Djamshidian, S.S. O'Sullivan, Y. Sanotsky, S. Sharman, Y. Matviyenko, T. Foltynie, R. Michalczuk, I. Aviles-Olmos, K. Doherty, M. Selikhova, H. Bowden-Jones, E. Joyce, A.J. Lees, B.B. Averbeck (London, United Kingdom)


Towards the detection of the neural correlates of Parkinson's disease sub-types using MRI

K. Rosenberg Katz, T. Herman, Y. Jacob, G. Nir, J.M. Hausdorff (Tel Aviv, Israel)


Rotigotine transdermal patch improved neuropsychiatric features (apathy, anhedonia, anxiety, and depression) and fatigue in patients with Parkinson's disease: Post-hoc analysis of five double-blind placebo-controlled studies

R.A. Hauser, P.A. Nausieda, E. Surmann, K. Moran, P. Barone (Tampa, FL, USA)


Morphologic changes of dendritic spines of intratelencephalic-type neurons in the motor cortex of a rat model of levodopa-induced dyskinesia

T. Ueno, H. Nishijima, A. Arai, K. Migita, J. Yamada, M. Baba, S. Ueno, M. Tomiyama (Aomori, Japan)


Effects of bilateral subthalamic nucleus deep brain stimulation on impulse control and repetitive behavior disorders in Parkinson's disease: Results from 89 patients

Y.E. Kim, H. Kim, H.J. Kim, J.Y. Lee, J.Y. Yun, J.Y. Kim, S.H. Paek, B.S. Jeon (Seoul, Korea)


Suicide ideation and behaviors after deep brain stimulation for Parkinson's disease: Results from a randomized, controlled trial

D. Weintraub, J. Duda, K. Carlson, P. Luo, O. Sagher, F. Weaver (Philadelphia, PA, USA)


Minor hallucinations are a frequent and even pre-motor symptom in early untreated Parkinson's disease

J. Pagonabarraga, S. Martinez-Horta, R. Fernández de Bobadilla, C. Villa, R. Ribosa, C. García, B. Pascual-Sedano, A. Gironell, J. Kulisevsky (Barcelona, Spain)


Thinning of retina from nasal part associates with visual hallucinatory experience in patients with Parkinson's disease wtih intact cognition

J.Y. Lee, T.W. Kim, H.J. Kim, B.S. Jeon (Seoul, Korea)

GUIDED POSTER TOUR 13 - Liffey Hall 1 Thursday, June 21, 2012 12:00 - 13:30



Clinical characteristics of dystonia in patients with Wilson's disease; the frequency of extensor truncal dystonia

A.S. Shalash, T.Y. AbdelGhaffar, S.M. Elsayed (Cairo, Egypt)


Neuropathology of primary cervical dystonia

C.N. Prudente, J. Xiao, C.A. Pardo-Villamizar, M.S. LeDoux, H.A. Jinnah (Atlanta, GA, USA)


Generation of a novel rodent model of DYT1 dystonia

K. Grundmann, T. Ott, N. Gloeckle, M. Walter, M. Bonin, H.P. Nguyen, T.K. Hauser, B. Fehrenbacher, M. Schaller, B. Nuscher, C. Haass, G. Martella, A. Pisani, Z. Yue, O. Riess (Tuebingen, Germany)


A rat knockin model of early onset DYT1 generalized dystonia displays abnormal hindlimb gait

C.T. Frenz, M. Singh, P. Shashidharan (New York, NY, USA)


Tremor dominant cervical dystonia is likely to be familial: Clinical characteristics of a large cohort

I. Rubio Agustí, I. Pareés, M. Kojovic, M.J. Edwards, K.P. Bhatia (London, United Kingdom)


Penetrance of abnormal temporal discrimination thresholds in unaffected first-degree relatives of adult onset primary torsion dystonia patients

O. Kimmich, A. Molloy, D. Bradley, R. Whelan, S. O'Riordan, R.B. Reilly, S. Hutchinson, M. Hutchinson (Dublin, Ireland)


Identification of the genetic cause in the Australian family with spasmodic dysphonia (DYT4)

S. Winkler, A. Ramirez, J. Nahrstaedt, C. Hemmelmann, J. Groen, J. Hagenah, M.A.J. de Koning-Tijssen, A. Ziegler, R.A. Wilcox, C. Klein, K. Lohmann (Lübeck, Germany)


Cerebellar modulation of human associative plasticity

M. Hamada, N. Murase, A. Sadnicka, J.M. Galea, M.J. Edwards, J.C. Rothwell (London, United Kingdom)


Myofibrillar disorganization characterizes myopathy of camptocormia in Parkinson's disease

A. Wrede, N.G. Margraf, H.H. Goebel, G. Deuschl, W.J. Schulz-Schaeffer (Göttingen, Germany)


Immunotherapy-responsive faciobrachial dystonic seizures (FBDS) associated with LGI1-antibodies: A differential diagnosis in movement disorder practice

S.R. Irani, S.A. Schneider, R. Pettingill, S.J.M. Smith, M.R. Johnson, A. Vincent (Oxford, United Kingdom)

GUIDED POSTER TOUR 14 - Liffey Hall 2 Thursday, June 21, 2012 12:00 - 13:30

Parkinsonisms (parkinson plus and secondary)


Abnormalities of voice quality in progressive supranuclear palsy (PSP)

S. Skodda, W. Grönheit, U. Schlegel (Bochum, Germany)


Atypical parkinsonian syndromes and fracture risk – Are patients adequately managed?

A.J. Yarnall, G.W. Duncan, T.K. Khoo, D.J. Burn (Newcastle-upon-Tyne, United Kingdom)


Pure parkinsonism in chorea-acanthocytosis: Postmortem evidence for a striato-pallidal process without involvement of the substantia nigra pars compacta

B.S. Connolly, L.N. Hazrati, A.E. Lang (Toronto, ON, Canada)


Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson's disease

H. Ling, L. Massey, A. Lees, P. Brown, B. Day (London, United Kingdom)


Update on ephedrone induced parkinsonism with dystonia: Four year follow up

Y. Sanotsky, M. Selikhova, L. Fedorishin, Y. Matvienko, I. Komnatska, H. Grey, E. Tripoliti, A.J. Lees (London, United Kingdom)


Impaired primary motor cortex LTP/LTD-like plasticity in multiple system atrophy

A. Suppa, L. Marsili, F. Di Stasio, A. Latorre, A. Khandker Parvez, C. Colosimo, G. Fabbrini, A. Berardelli (Rome, Italy)


Clinicopathological study of progressive supranuclear palsy presenting with corticobasal syndrome

H. Ling, R. de Silva, R. Courtney, L. Massey, N. Bajaj, J. Lowe, J. Holton, A. Lees, T. Revesz (London, United Kingdom)


Accuracy of the NINDS-SPSP and the NNIPPS diagnostic criteria for the clinical diagnosis of progressive supranuclear palsy

G. Respondek, S. Roeber, C. Gaig, C. Troakes, J. Van Swieten, W.H. Oertel, G.U. Hoeglinger (Munich, Germany)


Characterization of movement disorder phenomenology in genetically or pathologically proven frontotemporal lobar degeneration: A systematic review of the literature

B.B. Shah, M. Masellis, D. Harmic, D. Fisman, G. Kleiner-Fisman (Toronto, ON, Canada)


Parkinsonism in hereditary diffuse leukoencephalopathy with axonal spheroids due to CSF1R gene mutation

C. Sundal, J. Van Gerpen, A. Nicholson, M. Baker, C. Wider, E. Shuster, J. Aasly, S. Spina, B. Ghetti, S. Roeber, A. Tselis, R. Swerdlow, B. Miller, S. Fujioka, R. Uitti, O. Ross, R. Rademakers, K. Josephs, D. Dickson, Z. Wszolek (Jacksonville, FL, USA)

GUIDED POSTER TOUR 15 - Wicklow Hall 1 Thursday, June 21, 2012 12:00 - 13:30



Modulation of orthostatic tremor during gait

C. Blahak, M.E. Wolf, H. Bäzner, H.H. Capelle, J.K. Krauss, M.G. Hennerici (Mannheim, Germany)


Essential tremor and tremor associated with dystonia are two distinct clinical entities by tactile and proprioceptive temporal dicrimination tests

A. Fasano, T. Bovi, A. Di Matteo, A. Fiaschi, F. Bove, M. Fiorio, A. Berardelli, M. Tinazzi (Verona, Italy)


Long term history of orthostatic tremor: A review of 50 patients

F. Di Biasio, S.L. Pullman, J.C. Cortés, Q.P. Yu, C. Hess, S. Fahn (Rome, Italy)


Tremor clusters in the VIM associated with essential tremor and Parkinson's disease

D.J. Pedrosa, C. Reck, M. Maarouf, L. Wojtecki, A.M. Pauls, V. Sturm, A. Schnitzler, G.R. Fink, L. Timmermann (Cologne, Germany)


Mild cognitive impairment in essential tremor

M. Petrova, M. Raycheva, Y. Zhelev, O. Grigorova, L. Traykov (Sofia, Bulgaria)


Survey of cognitive screening in Parkinson's disease across UK centres

S. Hanumantha Reddy, B. Elliott, D. MacMahon, Delegates at the 16th BGS Parkinson's Academy (London, United Kingdom)


Identifying different pathological tremor characteristics with a smart phone

B. Carignan, J.F. Daneault, C.E. Codere, A.F. Sadikot, C. Duval (Terrebonne, QC, Canada)


Clinical features of parkinsonism with tremor associated with scans without evidence of dopaminergic deficit (SWEDDs)

A. Sacko, V. Moullart, C. Duru, P.E. Merle, O. Godefroy, P. Krystkowiak (Bobigny, France)


Corticomuscular coherence in asymptomatic first degree relatives of patients with essential tremor

J. Raethjen, A. Kostka, M. Muthuraman, M. Nahrwohld, D. Lorenz, G. Deuschl (Kiel, Germany)


Diagnosis of psychogenic tremor using a smartphone

T.A. Saifee, P. Kassavetis, L. Drougkas, G. Roussos, I. Pareés, P. Schwingenschuh, P. Katschnig, K.P. Bhatia, J.C. Rothwell, M.J. Edwards (London, United Kingdom)

GUIDED POSTER TOUR 16 - Wicklow Hall 2 Thursday, June 21, 2012 12:00 - 13:30

Surgical therapy of movement disorders other than Parkinson's disease


Factors predicting improvement in essential head tremor following deep brain stimulation

M. Moscovich, T. Morishita, C. Favilla, Z. Peng, K. Foote, M. Okun (Gainesville, FL, USA)


Evaluation of the therapeutic profit of nucleus accumbens core on the impulsivity/compulsivity balance in rats

S. Ansquer, A. Belin-Rauscent, E. Dugast, M. Francheteau, J.L. Houeto, D. Belin (Poitiers, France)


Cervical dystonia improves with high frequency but not with low frequency pallidal stimulation

E. Moro, B.M. Pascual-Sedano, B. Shah, Y.Y. Poon, M. Fallis, A.M. Lozano, M. Hodaie, P. Hagen, C. Brücke, G.H. Schneider, A. Kühn (Toronto, ON, Canada)


Electrophysiology of the anteromedial GPi in Tourette syndrome: A case study

S.E. Zauber, S. Ahn, R.M. Worth, L. Rubchinsky (Indianapolis, IN, USA)


Prospective assessment of low- versus high-frequency bilateral subthalamic nucleus (STN) deep brain stimulation (DBS) in patients with primary dystonia

J.L. Ostrem, G.A. Glass, L.C. Markun, C.A. Racine, M.M. Volz, S.L. Heath, P.A. Starr (San Francisco, CA, USA)


Treatment of tremor in multiple sclerosis by thalamic deep brain stimulation

F. Hofschulte, S. Paschen, J. Raethjen, H.M. Mehdorn, J. Volkmann, G. Deuschl (Kiel, Germany)


Successful GPi-Deep brain stimulation in Tourette syndrome (GTS) – Much more than improvement of tics

J.H. Mehrkens, K. Boetzel, B. Leitner, B. Feddersen, N. Müller, S. Dehning (Munich, Germany)


Effect of bilateral pallidal deep brain stimulation in primary dystonia

F. Yokochi, M. Taniguchi, R. Okiyama, S. Kumada (Tokyo, Japan)


Long-term follow-up in patients with deep brain stimulation for cervical dystonia

M.W.M. Schüpbach, H. You, I.U. Isaias, T. Loennfors- Weitzel, F. Vingerhoets, J.K. Krauss, J.M. Burgunder, E. Taub, A. Stibal, A. Kaelin-Lang (Bern, Switzerland)


A double-blind, randomized, controlled, crossover trial of bilateral deep brain stimulation to the globus pallidus internus in severe Tourette syndrome

Z. Kefalopoulou, L. Zrinzo, M. Beigi, M. Hariz, M. Jahanshahi, P. Limousin, E. Joyce, T. Foltynie (London, United Kingdom)